Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.

Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, Barre P, Magner P, Muirhead N, Tobe S, Tam P, Wadgymar JA, Kappel J, Holland D, Pichette V, Shoker A, Soltys G, Verrelli M, Singer J.

Am J Kidney Dis. 2005 Nov;46(5):799-811.

PMID:
16253719
[PubMed - indexed for MEDLINE]
2.

Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease.

Kimel M, Leidy NK, Mannix S, Dixon J.

Value Health. 2008 Jan-Feb;11(1):57-75. doi: 10.1111/j.1524-4733.2007.00215.x. Review.

PMID:
18237361
[PubMed - indexed for MEDLINE]
3.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
4.

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis.

Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P.

Clin J Am Soc Nephrol. 2009 Apr;4(4):755-62. doi: 10.2215/CJN.02730608. Epub 2009 Apr 1. Review.

PMID:
19339417
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE.

Am J Med. 2003 Jul;115(1):41-6. Review.

PMID:
12867233
[PubMed - indexed for MEDLINE]
6.

Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.

Jones M, Schenkel B, Just J.

Int J Cardiol. 2005 Apr 20;100(2):253-65. Review.

PMID:
15823633
[PubMed - indexed for MEDLINE]
7.

Normalization of haemoglobin: why not?

Jacobs C.

Nephrol Dial Transplant. 1999;14 Suppl 2:75-9. Review.

PMID:
10334671
[PubMed - indexed for MEDLINE]
Free Article
8.

[TREAT or not to treat: anemia in type 2 diabetes and chronic kidney disease at stages 3 and 4].

Choukroun G, Renou M, Lecaque C, Jauréguy M.

Nephrol Ther. 2011 Feb;7(1):2-9. doi: 10.1016/j.nephro.2010.11.003. Epub 2011 Jan 8. Review. French.

PMID:
21216683
[PubMed - indexed for MEDLINE]
9.

Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?

Berns JS.

Curr Opin Nephrol Hypertens. 2010 Nov;19(6):567-72. doi: 10.1097/MNH.0b013e32833c3cc7. Review.

PMID:
20601876
[PubMed - indexed for MEDLINE]
10.

Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis.

Tai DJ, Lim TW, James MT, Manns BJ, Tonelli M, Hemmelgarn BR; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2010 Apr;5(4):623-30. doi: 10.2215/CJN.07831109. Epub 2010 Feb 4. Review.

PMID:
20133488
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Attaining target hemoglobin levels in patients new to dialysis: individualizing therapy based on initial hemoglobin levels.

Gregory N.

Nephrol Nurs J. 2004 Nov-Dec;31(6):672-5. Review.

PMID:
15686331
[PubMed - indexed for MEDLINE]
12.

Effect of erythropoietin on cardiovascular diseases.

Sunder-Plassmann G, Hörl WH.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S20-5. Review.

PMID:
11576916
[PubMed - indexed for MEDLINE]
13.

What are the short-term and long-term consequences of anaemia in CRF patients?

Mann JF.

Nephrol Dial Transplant. 1999;14 Suppl 2:29-36. Review.

PMID:
10334665
[PubMed - indexed for MEDLINE]
Free Article
14.

The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?

Covic A, Voroneanu L, Goldsmith D.

Nephron Clin Pract. 2010;116(3):c187-95. doi: 10.1159/000317198. Epub 2010 Jul 2. Review.

PMID:
20606478
[PubMed - indexed for MEDLINE]
Free Article
15.

Antihypertensive drugs and the heart.

Diamond JA, Phillips RA.

Curr Cardiol Rep. 2004 Nov;6(6):409-15. Review.

PMID:
15485599
[PubMed - indexed for MEDLINE]
16.

The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.

Weir MR.

Am J Hypertens. 2005 Apr;18(4 Pt 2):100S-105S. Review.

PMID:
15837552
[PubMed - indexed for MEDLINE]
17.

Diuretics in the prevention and treatment of congestive heart failure.

Moser M.

Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:273-7. Review.

PMID:
9211020
[PubMed - indexed for MEDLINE]
18.

Is there a role for adjuvant therapy in patients being treated with epoetin?

Hörl WH.

Nephrol Dial Transplant. 1999;14 Suppl 2:50-60. Review.

PMID:
10334668
[PubMed - indexed for MEDLINE]
Free Article
19.

Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.

Schmid H, Schiffl H, Lederer SR.

Curr Opin Nephrol Hypertens. 2011 Sep;20(5):465-70. doi: 10.1097/MNH.0b013e3283497057. Review.

PMID:
21738032
[PubMed - indexed for MEDLINE]
20.

Clinical trials of single-drug therapy for the cardiac effects of hypertension.

Gottdiener JS.

Am J Hypertens. 1999 Jan;12(1 Pt 2):12S-18S. Review.

PMID:
10077415
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk